Is AMD Stock an All-Time Buy?
Advanced Micro Devices (NASDAQ:AMD) is a high-growth AI stock that…
Sell
40
MOH Quote, Financials, Valuation and Earnings
Last price:
$291.59
Seasonality move
:
10.24%
Day range:
$290.31 - $297.39
52-week range:
$272.69 - $423.92
Dividend yield:
0%
P/E ratio:
14.94x
P/S ratio:
0.44x
P/B ratio:
3.53x
Volume:
290.5K
Avg. volume:
691K
1-year change:
-17.77%
Market cap:
$16.8B
Revenue:
$34.1B
EPS (TTM):
$19.69
Analysts' Opinion
-
Consensus RatingMolina Healthcare has received a consensus rating of Hold. The company's average rating is a Hold based on 5 Buy ratings, 8 Hold ratings, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $360.77, Molina Healthcare has an estimated upside of 22.64% from its current price of $294.18.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $309.00 representing -5.04% downside risk from its current price of $294.18.
Fair Value
-
According to the consensus of 13 analysts, Molina Healthcare has 22.64% upside to fair value with a price target of $360.77 per share.
MOH vs. S&P 500
-
Over the past 5 trading days, Molina Healthcare has underperformed the S&P 500 by -2.57% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
Molina Healthcare does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Molina Healthcare has grown year-over-year revenues for 19 quarters straight. In the most recent quarter Molina Healthcare reported revenues of $10.3B.
Earnings Growth
-
Molina Healthcare has grown year-over-year earnings for 1 quarter straight. In the most recent quarter Molina Healthcare reported earnings per share of $5.65.
Enterprise value:
9.9B
EV / Invested capital:
1.40x
Price / LTM sales:
0.44x
EV / EBIT:
6.05x
EV / Revenue:
0.25x
PEG ratio (5yr expected):
0.66x
EV / Free cash flow:
105.80x
Price / Operating cash flow:
181.75x
Enterprise value / EBITDA:
5.45x
Gross Profit (TTM):
$4.7B
Return On Assets:
7.51%
Net Income Margin (TTM):
2.92%
Return On Equity:
25.77%
Return On Invested Capital:
17.2%
Operating Margin:
4.52%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2023-09-30 | 2024-09-30 | |
| Income Statement | ||||||
| Revenue | $31.2B | $33.2B | $39.2B | $8.5B | $10.3B | |
| Gross Profit | $3.8B | $4.3B | $4.7B | $1.1B | $1.2B | |
| Operating Income | $1.3B | $1.6B | $1.6B | $359M | $467M | |
| EBITDA | $1.4B | $1.5B | $1.8B | $401M | $514M | |
| Diluted EPS | $14.33 | $16.04 | $19.69 | $4.21 | $5.65 | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $7B | $9.4B | $10.5B | $12.5B | $12.9B | |
| Total Assets | $7.9B | $11B | $12.8B | $14.9B | $15.8B | |
| Current Liabilities | $3.6B | $6.1B | $7.2B | $8.5B | $8.3B | |
| Total Liabilities | $5.7B | $8.5B | $9.8B | $11B | $11B | |
| Total Equity | $2.2B | $2.5B | $3B | $3.9B | $4.8B | |
| Total Debt | $1.8B | $2.1B | $2.2B | $2.2B | $2.3B | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2023-09-30 | 2024-09-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $1.6B | $2.1B | $178M | $949M | $873M | |
| Cash From Investing | -$1.5B | -$571M | -$508M | -$280M | -$48M | |
| Cash From Financing | -$237M | -$244M | -$411M | -$6M | -$364M | |
| Free Cash Flow | $1.5B | $2B | $94M | $923M | $838M | |
MOH
Sector
Market Cap
$16.8B
$46.5M
Price % of 52-Week High
69.39%
47.23%
Dividend Yield
0%
0%
Shareholder Yield
--
-0.6%
1-Year Price Total Return
-17.77%
-31.38%
Beta (5-Year)
0.536
0.772
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Technicals
8-day SMA
Sell
Level
$294.50
200-day SMA
Sell
Level
$332.32
Bollinger Bands (100)
Sell
Level
301.65 - 346.01
Chaikin Money Flow
Buy
Level
76.9M
20-day SMA
Sell
Level
$298.76
Relative Strength Index (RSI14)
Sell
Level
44.81
ADX Line
Buy
Level
10.04
Williams %R
Neutral
Level
-77.3797
50-day SMA
Sell
Level
$305.80
MACD (12, 26)
Sell
Level
-3.65
25-day Aroon Oscillator
Buy
Level
36
On Balance Volume
Neutral
Level
118.9M
Financial Scores
Buy
Altman Z-Score
(Annual)
Level (4.5381)
Buy
CA Score
(Annual)
Level (-0.0429)
Buy
Beneish M-Score
(Annual)
Level (-2.4058)
Buy
Momentum Score
Level (4)
Buy
Ohlson Score
Level (-0.1017)
Buy
Piotroski F Score
(Annual)
Level (8)
Buy
Quality Ratio Score
Level (5)
Buy
Fundamental Score
Level (8)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Molina Healthcare Inc offers healthcare plans focused on Medicaid-related solutions for low-income families and individuals. Its health plans are operated by a network of subsidiaries, each of which is licensed as a health maintenance organization (HMO). It has four segments: Medicaid, Medicare, Marketplace and Others. The Medicaid, Medicare, and Marketplace segments represent the government-funded or sponsored programs under which it offers managed healthcare services. The Other segment, which is insignificant to its consolidated results of operations, includes long-term services and supports consultative services in Wisconsin. It generates majority revenue from Medicaid segment.
Stock Forecast FAQ
In the current month, MOH has received 5 Buy ratings 8 Hold ratings, and 0 Sell ratings. The MOH average analyst price target in the past 3 months is $360.77.
-
Where Will Molina Healthcare Stock Be In 1 Year?
According to analysts, the consensus estimate is that Molina Healthcare share price will rise to $360.77 per share over the next 12 months.
-
What Do Analysts Say About Molina Healthcare?
Analysts are divided on their view about Molina Healthcare share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Molina Healthcare is a Sell and believe this share price will drop from its current level to $309.00.
-
What Is Molina Healthcare's Price Target?
The price target for Molina Healthcare over the next 1-year time period is forecast to be $360.77 according to 13 Wall Street analysts, 5 of them rate the stock a Buy, 0 rate the stock a Sell, and 8 analysts rate the stock a Hold.
-
Is MOH A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Molina Healthcare is a Hold. 8 of 13 analysts rate the stock a Hold at this time.
-
How Can I Buy Shares Of MOH?
You can purchase shares of Molina Healthcare via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, TastyTrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Molina Healthcare shares.
-
What Is The Molina Healthcare Share Price Today?
Molina Healthcare was last trading at $291.59 per share. This represents the most recent stock quote for Molina Healthcare. Yesterday, Molina Healthcare closed at $294.18 per share.
-
How To Buy Molina Healthcare Stock Online?
In order to purchase Molina Healthcare stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
How High Will Airbnb Stock Go?
Airbnb, Inc. (NASDAQ:ABNB) share price has seen substantial turbulence over…
Why Is SoundHound AI Stock Up So Much?
Like many companies improving AI technologies and exploring ways to…
Stock Ideas
Buy
65
Is AAPL Stock a Buy?
Market Cap: $3.9T
P/E Ratio: 43x
Buy
56
Is NVDA Stock a Buy?
Market Cap: $3.4T
P/E Ratio: 117x
Buy
57
Is MSFT Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 37x
Alerts
Buy
64
ARQQ alert for Dec 27
Arqit Quantum [ARQQ] is down 7.48% over the past day.
Buy
64
QMCO alert for Dec 27
Quantum [QMCO] is up 1.11% over the past day.
Buy
65
ALGS alert for Dec 27
Aligos Therapeutics [ALGS] is down 4.61% over the past day.
